Garner Health
Garner Health is a healthcare technology company that uses a data analytics platform to help people find top-performing doctors.
Secondary Market Price
Secondary Market Price
How Garner Health Measures Up
To help you manage your Garner Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still gathering data and evaluating Garner Health. Check back soon for our rating on what the company may be worth four years from now.
Exit Risk
TBD
We are still gathering data on Garner Health to train our machine learning model. Check back soon for our exit risk rating for Garner Health!
Funding Stage
Series B
Garner Health's Series B status means it's a more established company with a proven business model. This offers a sweet spot between the high-risk environment of an early-stage startup and the slower pace of a large corporation.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Garner Health's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Garner Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Garner Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Garner Health is a healthcare technology company that provides a data analytics platform designed to help employees find high-quality doctors. The platform analyzes a database of medical records, which the company states includes 320 million patient records, to identify top-performing physicians. It also offers a concierge service to help users find in-network providers and reimburses certain out-of-pocket medical costs. Founded in 2019 by CEO Nick Reber, the New York-based company has raised $70.1 million in total funding. Key funding rounds include a Seed Round in January 2020 and a $45 million Series B round in December 2021, with backing from investors such as Redpoint, Founders Fund, and Thrive Capital.
The company continues to develop its platform, with a projected IT spend of $4.7 million for the current year. Garner Health also produces thought leadership content, including its 'Margin of Care' podcast, which explores topics like the impact of GLP-1s on obesity treatment and the role of AI in healthcare. In addition, the company engages with industry stakeholders through live events, such as a recent discussion with CEO Nick Reber about data on how Americans find doctors and the implications for employer benefit design.
- Founders Fund
- Thrive Capital
- Redpoint
- Optum
- Founder, CEO Nick Reber
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Garner Health worth joining?
Whether a private company like Garner Health is worth joining depends on its growth potential and your personal career goals. Platforms like Prospect can help you evaluate the opportunity by providing data-driven projections on the company's future value.
What should I do with my Garner Health stock?
Managing private company stock involves complex decisions regarding exercising options, tax planning, and timing liquidity. Using a service like Prospect can provide personalized, tax-optimized strategies and scenario modeling to help you maximize your equity's value.
Can you sell Garner Health stock?
Selling stock in a private company is typically possible through secondary markets or company-approved liquidity events, such as tender offers. Tools from platforms like Prospect can help you navigate these events by providing market data and guidance on tax-optimal selling strategies.
How can I find the value of my Garner Health stock?
The value of private stock is formally determined by a 409A valuation, but this doesn't reflect future potential. You can get a more forward-looking estimate using platforms like Prospect, which apply predictive models to project future share value based on venture capital data.
What is Garner Health's equity worth?
As a private company, Garner Health's equity does not have a publicly traded market price, and its value is typically based on its most recent funding round valuation. To better understand its potential worth, you can use an equity calculator or evaluation platform that analyzes factors like funding, growth, and investor quality.
What is Garner Health's stock ticker symbol?
Garner Health is a private company, so it does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Garner Health stock?
As a private company, buying Garner Health stock is generally limited to accredited investors or employees, while selling can occur during specific liquidity events or on secondary markets. While platforms like Prospect provide tools to evaluate equity and plan for sales, they do not function as a marketplace for buying or selling shares.
What is the criteria to buy or invest in Garner Health stock?
Investing in a private company like Garner Health is typically restricted to employees receiving equity compensation or accredited investors participating in official funding rounds. Some secondary markets may also offer shares to qualified buyers, but access is often limited and regulated.
